Karyopharm Therapeutics
KPTI
#9746
Rank
C$46.7 M
Marketcap
$5.55
Share price
-2.97%
Change (1 day)
202.14%
Change (1 year)

EPS for Karyopharm Therapeutics (KPTI)

EPS in 2023 (TTM): -$1.78

According to Karyopharm Therapeutics 's latest financial reports the company's current EPS (TTM) is -$1.87. In 2022 the company made an earnings per share (EPS) of -$2.87 a decrease over its 2021 EPS that were of -$2.35.

EPS history for Karyopharm Therapeutics from 2013 to 2023

Annual EPS

Year EPS Change
2023 (TTM)-$1.78-38.02%
2022-$2.8722.29%
2021-$2.35-39.19%
2020-$3.86-15.48%
2019-$4.573.19%
2018-$4.4311.79%
2017-$3.96-4.44%
2016-$4.15-11.75%
2015-$4.7037.76%
2014-$3.41-74.5%
2013-$13.38

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$2.58-238.01%๐Ÿ‡บ๐Ÿ‡ธ USA
$5.62-400.76%๐Ÿ‡บ๐Ÿ‡ธ USA
$4.21-325.17%๐Ÿ‡บ๐Ÿ‡ธ USA
$0.40-121.46%๐Ÿ‡บ๐Ÿ‡ธ USA